| Policies for biosimilar uptake in Europe: an overview E Moorkens, AG Vulto, I Huys, P Dylst, B Godman, S Keuerleber, B Claus, ... PloS one 12 (12), e0190147, 2017 | 236 | 2017 |
| The duration of infectiousness of individuals infected with SARS-CoV-2 KA Walsh, S Spillane, L Comber, K Cardwell, P Harrington, J Connell, ... Journal of Infection 81 (6), 847-856, 2020 | 181 | 2020 |
| Pharmaceutical regulation in 15 European countries D Panteli, F Arickx, I Cleemput, G Dedet, H Eckhardt, E Fogarty, ... Health systems in transition 18 (5), 1-118, 2016 | 169 | 2016 |
| Are new models needed to optimize the utilization of new medicines to sustain healthcare systems? B Godman, RE Malmström, E Diogene, A Gray, S Jayathissa, A Timoney, ... Expert review of clinical pharmacology 8 (1), 77-94, 2015 | 164 | 2015 |
| Trends in alcohol-induced deaths in the United States, 2000-2016 S Spillane, MS Shiels, AF Best, EA Haozous, DR Withrow, Y Chen, ... JAMA network open 3 (2), e1921451-e1921451, 2020 | 123 | 2020 |
| A cohort study of metformin exposure and survival in patients with stage I–III colorectal cancer S Spillane, K Bennett, L Sharp, TI Barron Cancer epidemiology, biomarkers & prevention 22 (8), 1364-1373, 2013 | 105 | 2013 |
| Association of cardiovascular disease with premature mortality in the United States Y Chen, ND Freedman, PS Albert, RR Huxley, MS Shiels, DR Withrow, ... JAMA cardiology 4 (12), 1230-1238, 2019 | 83 | 2019 |
| Infant and youth mortality trends by race/ethnicity and cause of death in the United States SQ Khan, AB de Gonzalez, AF Best, Y Chen, EA Haozous, EJ Rodriquez, ... JAMA pediatrics 172 (12), e183317-e183317, 2018 | 80 | 2018 |
| Dabigatran-a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs B Godman, RE Malmström, E Diogene, S Jayathissa, S McTaggart, T Cars, ... Frontiers in pharmacology 5, 109, 2014 | 63 | 2014 |
| Premature mortality from all causes and drug poisonings in the USA according to socioeconomic status and rurality: an analysis of death certificate data by county from 2000–15 MS Shiels, AB de González, AF Best, Y Chen, P Chernyavskiy, P Hartge, ... The Lancet Public Health 4 (2), e97-e106, 2019 | 62 | 2019 |
| Trends in mortality from drug poisonings, suicide, and alcohol-induced deaths in the United States from 2000 to 2017 MS Shiels, Z Tatalovich, Y Chen, EA Haozous, P Hartge, AM Nápoles, ... JAMA network open 3 (9), e2016217-e2016217, 2020 | 51 | 2020 |
| Generic medicines and generic substitution: contrasting perspectives of stakeholders in Ireland A O’Leary, C Usher, M Lynch, M Hall, L Hemeryk, S Spillane, P Gallagher, ... BMC research notes 8, 1-10, 2015 | 42 | 2015 |
| Trends in premature deaths among adults in the United States and Latin America Y Chen, ND Freedman, EJ Rodriquez, MS Shiels, AM Napoles, ... JAMA network open 3 (2), e1921085-e1921085, 2020 | 27 | 2020 |
| Metformin exposure and disseminated disease in patients with colorectal cancer S Spillane, K Bennett, L Sharp, TI Barron Cancer epidemiology 38 (1), 79-84, 2014 | 22 | 2014 |
| Trends in mortality due to cancer in the United States by age and county-level income, 1999–2015 DR Withrow, A Berrington de González, S Spillane, ND Freedman, ... JNCI: Journal of the National Cancer Institute 111 (8), 863-866, 2019 | 19 | 2019 |
| Trends in opioid use among cancer patients in the United States: 2013-2018 Y Chen, S Spillane, MS Shiels, L Young, D Quach, ... JNCI Cancer Spectrum 6 (1), pkab095, 2022 | 14 | 2022 |
| Interventions in an ambulatory setting to prevent progression to severe disease in patients with COVID-19: a systematic review E O Murchu, S Spillane, P Byrne, M O’Neill, P Harrington, M Ryan Annals of Pharmacotherapy 56 (3), 309-318, 2022 | 10 | 2022 |
| Effectiveness of rapid antigen testing for screening of asymptomatic individuals to limit the transmission of SARS‐CoV‐2: A rapid review KA Walsh, N Broderick, S Ahern, CG Fawsitt, KM O’Brien, M Carrigan, ... Reviews in Medical Virology 32 (5), e2350, 2022 | 9 | 2022 |
| Organ dysfunction in patients with advanced melanoma treated with immune checkpoint inhibitors S Spillane, S Baxi, AZ Torres, D Lenis, AN Freedman, AB Mariotto, ... The Oncologist 25 (11), e1753-e1762, 2020 | 8 | 2020 |
| Introduction of generic substitution and reference pricing in Ireland: early effects on state pharmaceutical expenditure and generic penetration, and associated success factors S Spillane, C Usher, K Bennett, R Adams, M Barry Journal of Pharmaceutical Policy and Practice 8 (sup1), O10, 2015 | 6 | 2015 |
Meredith ShielsNational Cancer InstituteVerified email at mail.nih.gov
